Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

737 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

NCT05828069

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 120 locations
View Trial Details
Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

NCT07652658

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Loma Linda, California, United States
View all 195 locations
View Trial Details
Recruiting

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

NCT07516951

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • PHI University Clinic of Pulmonology and Allergology Skopje, North Macedonia
  • Premier Pulmonary Critical Care and Sleep Medicine, PA Denison, Texas, United States
  • Hannibal Regional Healthcare System, Inc. Hannibal, Missouri, United States
View Trial Details
Recruiting

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis

NCT05841758

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations
  • Service de Médecine Interne Infectiologie Aïgue Polyvalente- Hôpital Henri Duffaud Avignon, France
  • Service de Pneumologie - Hôpital Avicenne Bobigny, France
  • Service de medecine interne - Hôpital Henri Mondor Créteil, France
  • Service de Médecine Interne et Immunologie Clinique - CHU Dijon Bourgogne Dijon, France
View all 21 locations
View Trial Details
Recruiting

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT07687459

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Anhui Chest Hospital Hefei, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 47 locations
View Trial Details
Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034

Conditions
Adjustment Disorder, Adjustment Disorders, Amyotrophic Lateral Sclerosis, +28 more
Locations
  • UAB, Psychiatry and Behavioral Neurology Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Kadima Neuropsychiatry Institute San Diego, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 32 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View all 19 locations
View Trial Details

Related conditions